Stay updated on ONO-4538 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the ONO-4538 in NSCLC Clinical Trial page.

Latest updates to the ONO-4538 in NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a new release of the page. No substantive content changes are observed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedTaoyuan, Taiwan was added to the list of study sites and Taoyuan District, Taiwan was removed. This changes the geographic distribution of TASUKI-52 locations.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page footer’s software/UI revision indicator has been updated from “v3.5.2” to “v3.5.3,” reflecting an incremental site release rather than a change to the clinical study information.SummaryDifference0.0%

- Check34 days agoChange DetectedUpdated sponsor name from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and updated page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check41 days agoChange DetectedPublication section updated: added full citation for Cancer Sci. 2026 (TASUKI-52 Four-Year Outcomes) and removed the online-ahead-of-print citation.SummaryDifference0.0%

- Check63 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to ONO-4538 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONO-4538 in NSCLC Clinical Trial page.